eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJuYW1laWQiOiIyYjZiZjc2Ni0wNGYxLTRlYWUtOTM1MC03OGNlMDFmNzhhMTYiLCJyb2xlIjoiQXBpVXNlciIsIm5iZiI6MTc1MDY4NjE5MywiZXhwIjoxNzUwNjg3MzkzLCJpYXQiOjE3NTA2ODYxOTMsImlzcyI6Imh0dHBzOi8vd3d3Lm1pbnRlcmVsbGlzb24uY29tL3Blb3BsZS9jaGVsc2VhLWdvcmRvbiIsImF1ZCI6Imh0dHBzOi8vd3d3Lm1pbnRlcmVsbGlzb24uY29tL3Blb3BsZS9jaGVsc2VhLWdvcmRvbiJ9.MnMFqNRQ75vHeGLr2-gepdq5vEYCP56QcnjOHsk4d40
https://www.minterellison.com/people/chelsea-gordon
CLOSE
CONTACT US Search Minter Ellison
Chelsea Gordon
AI Advisory Lead – Legal, Sydney
Chelsea Gordon is the Legal Lead in our AI Advisory team and excels in AI regulation, governance and Responsible AI. Chelsea enables to help clients maximise AI opportunities while mitigating legal risks. She has deep expertise in health and life sciences, including health regulation, novel technology, health funding, service contracting, clinical trials, and therapeutic goods.

Chelsea is a strategic thinker, who advises organisations about how to implement AI and other emerging technologies to achieve legally sound, commercial and strategic outcomes.

As a Legal Lead in MinterEllison’s AI Advisory practice, Chelsea guides boards and executive teams on AI governance frameworks, Responsible AI implementation and regulatory compliance. She supports clients in developing privacy and contract settings that protect personal information and intellectual property and align with AI risk management and ESG obligations. Chelsea advises ASX-listed companies and government across regulated sectors, including healthcare, education and financial services.

Chelsea also serves as the Australian Ambassador for the Global Council of Responsible AI, reflecting her leadership in shaping AI ethics, policy and best-practice governance.

Career highlights

  • Developed AI governance programs for various large international and national healthcare providers, addressing fragmented AI adoption, regulatory uncertainty, and operational risk across multiple jurisdictions via board, executive, and stakeholder engagement and the design and delivery of key responsible AI policies and processes.
  • Advised a national private equity firm on Responsible AI governance and disclosure obligations, as well as legal and ethical standards applicable to its portfolio companies across sectors including financial services, healthcare, and education.
  • Advised national education providers on responsible AI use in learning environments, including managing risks associated with vulnerable users such as children acting as AI deployers.
  • Provided privacy advice to multiple ASX-listed companies, large government departments and state corporations, including with a focus on safe and responsible artificial intelligence adoption.
  • Drafted AI procurement terms for large government departments.
  • Advised Local Health Districts in NSW and Hospital and Health Services in Queensland about how to create appropriate settings to enable appropriate privacy settings for the use of data for research and commercialisation.
  • Lead and advised various government departments across Australia in relation to large government contracts to improve accessibility to vital health services, including hospitals, urgent care and cancer treatment centres.
  • Advised several clients in relation to complex healthcare regulatory issues, including TGA advertising compliance, anti kick-back laws and health funding laws.
  • Advised several clients in relation to AI policies and assurance activities.
  • Advised government, local private entities and in bound investors into the healthcare sector on a range of issues including regulation of dangerous drugs, regulation of diagnostic imaging and pathology businesses, compliance with TGA registration requirements and advertising restrictions.
  • Negotiated agreements and advised in relation to legal risks arising from research and clinical trial arrangements.

© 2025 MinterEllison